Adolescent Behavior — Analysis of COMPASsion and Humanisation of Adolescents Facing the End-of-life Processes.
Citation(s)
Abad Corpa E, Delgado Hito P, Cabrero García J La investigación-acción-participativa: Una forma de investigar en la práctica enfermera. Investig y Educ en Enfermería. 2010;28(3):464-74.
Abel J, Bowra J, Walter T, Howarth G Compassionate community networks: supporting home dying. BMJ Support Palliat Care. 2011 Sep;1(2):129-33. doi: 10.1136/bmjspcare-2011-000068.
Abel J Compassionate communities and end-of-life care. Clin Med (Lond). 2018 Feb;18(1):6-8. doi: 10.7861/clinmedicine.18-1-6.
Chambers E, Gardiner C, Thompson J, Seymour J Patient and carer involvement in palliative care research: An integrative qualitative evidence synthesis review. Palliat Med. 2019 Sep;33(8):969-984. doi: 10.1177/0269216319858247. Epub 2019 Jun 28.
Chang, Fresco, & Green The Development and Validation of the Compassion of Others' Lives Scale (The COOL Scale). International Journal of Humanities and Social Science. 2014; 4 (5): 33-42.
Farquhar MC, Ewing G, Booth S Using mixed methods to develop and evaluate complex interventions in palliative care research. Palliat Med. 2011 Dec;25(8):748-57. doi: 10.1177/0269216311417919. Epub 2011 Aug 1.
Ivankova, N (2017). Applying mixed methods in community-based participatory action research: a framework for engaging stakeholders with research as a means for promoting patient-centredness. Journal of Research in Nursing, 22 (4), 282-294.
Ivankova, N , & Wingo, N. (2018). Applying mixed methods in actions research: methodological potentials and advantages. American Behavioral Scientist, 62(7), 978-997.
Kellehear, A Lowton, Karen. Compassionate Cities. Public Health and End of Life Care. Sociology of health & illness Volume: 30 Issue 1 (2008) ISSN: 0141-9889
Kemmis S, McTaggart R, Nixon R The action research planner: Doing critical participatory action research. The Action Research Planner: Doing Critical Participatory Action Research. 2014. 1-200 p.
Klos, M C., & Lemos, V. N. (2018). Adaptación y validación de un instrumento para evaluar el constructo compasión. Revista Evaluar, 18(2), 31-44. Recuperado de https://revistas.unc.edu.ar/index.php/revaluar
Soderhamn U, Flateland S, Fensli M, Skaar R To be a trained and supported volunteer in palliative care - a phenomenological study. BMC Palliat Care. 2017 Mar 14;16(1):18. doi: 10.1186/s12904-017-0193-0.
Tashakkori A, Teddlie C (2012). Utilizing mixed-methods in psychological research. Weiner, I, Schinka JA, Velicer WF. Handbook of Psychology, Research Methods in Psychology. (N.º 2 edición. (19 octubre 2012). Wiley.
Tomas-Sabado J, Gomez-Benito J Psychometric properties of the Spanish form of Templer's Death Anxiety Scale. Psychol Rep. 2002 Dec;91(3 Pt 2):1116-20. doi: 10.2466/pr0.2002.91.3f.1116.
Vanderstichelen S Palliative care volunteering: Pressing challenges in research. Palliat Med. 2022 Apr;36(4):564-566. doi: 10.1177/02692163221089483. Epub 2022 Mar 31. No abstract available.
Zarco Colón, J , Ramasco Gutiérrez, M., Pedraz Marcos, A., & Palmar Santos, A. M. (2019). Investigación cualitativa en salud (Vol. 58). CIS.
Analysis of COMPASsion and Humanisation of Adolescents Facing the End-of-life Processes: a Mixed-method Participatory Project
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
